title: Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab.
authors.affiliation: Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Ozturk
authors.initials: O
authors.lastname: Ates
authors.forename: Veli
authors.initials: V
authors.lastname: Sunar
authors.forename: Taner
authors.initials: T
authors.lastname: Babacan
authors.forename: Serkan
authors.initials: S
authors.lastname: Akin
authors.forename: Neyran
authors.initials: N
authors.lastname: Kertmen
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000368:Aged; D000799:Angioedema / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D050718:Complement C1 Inhibitor Protein / Q000378:metabolism*; D015536:Down-Regulation; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D015415:Biomarkers; D050718:Complement C1 Inhibitor Protein; D000069283:Rituximab